Marriott Tina — SEC Form 4 filings

SEC reporting owner CIK 1856414. 15 Form 4 filings on record with FilingPulse; latest filed 2024-11-19.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-01-29 to 2024-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RECURSION PHARMACEUTICALS, INC. (RXRX)President and COO1511 legs · 60,000 sh · $554,58228

Form 4 filings — Marriott Tina

FiledFormIssuerReported transactionsSource
2024-11-194RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 14,286 @ $6.17EDGAR
2024-10-284RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 6,000 @ $1.06 · Sale (S): 6,000 @ $6.31 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2024-09-304RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 6,000 @ $1.06 · Sale (S): 6,000 @ $7.00 · Option exercise (M): 0 (derivative) @ $0EDGAR
2024-09-034RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 6,000 @ $1.06 · Sale (S): 6,000 @ $7.56 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2024-08-194RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 14,319 @ $6.69EDGAR
2024-07-294RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 6,000 @ $1.06 · Sale (S): 6,000 @ $8.13 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2024-06-284RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 6,000 @ $1.06 · Sale (S): 6,000 @ $7.21 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2024-06-034RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 3,000 @ $1.06 · Sale (S): 3,000 @ $8.78 · Option exercise (M): 0 (derivative) @ $0EDGAR
2024-05-174RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 9,998 @ $10.01EDGAR
2024-04-294RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 3,000 @ $1.06 · Sale (S): 3,000 @ $7.67 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2024-03-254RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 8,000 @ $1.06 · Sale (S): 7,390 @ $10.70 · Sale (S): 610 @ $11.34 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2024-02-234RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 8,000 @ $1.06 · Sale (S): 8,000 @ $14.89 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2024-02-164RECURSION PHARMACEUTICALS, INC. (RXRX)Tax withholding (F): 5,379 @ $12.43EDGAR
2024-02-134RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 9,655 @ $0 · Grant/award (A): 223,958 @ $0 · Tax withholding (F): 2,800 @ $10.09 · Grant/award (A): 447,917 (derivative) @ $0EDGAR
2024-01-294RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 8,000 @ $1.06 · Sale (S): 8,000 @ $10.35 · Option exercise (M): 8,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1856414 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →